Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$5.91 USD
+0.34 (6.10%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $5.85 -0.06 (-1.02%) 6:56 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.46 | 21.22% |
Earnings Summary
For their last quarter, Foghorn Therapeutics (FHTX) reported earnings of -$0.45 per share, beating the Zacks Consensus Estimate of $-0.60 per share. This reflects a positive earnings surprise of 25.00%. Look out for FHTX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year decrease of 35.29%.
Earnings History
Price & Consensus
Zacks News for FHTX
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
FHTX: What are Zacks experts saying now?
Zacks Private Portfolio Services